Azixa verubulin: Phase II data

A Phase II trial in 31 patients with recurrent GBM naïve to treatment with bevacizumab showed that once-weekly 3.3 mg/m

Read the full 200 word article

How to gain access

Continue reading with a
two-week free trial.